Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Anthony J Messina"'
Autor:
Dipnarine Maharaj, Pedro G. Vianna, Wendy Ward, Anthony J. Messina, Trevor Rayborn, Jacqueline V. Gouvea, Richard D. Hammer, Zheng Cui
Publikováno v:
Heliyon, Vol 3, Iss 10, Pp e00438- (2017)
Background: In the past decade, a variety of immunotherapy approaches focused predominantly on the adaptive immune system have shown unprecedented responses in patients with advanced-stage malignancies. However, studies in spontaneous regression/comp
Externí odkaz:
https://doaj.org/article/78d3c2cfa10547e4bcc0a790ebb5fc13
Autor:
Anthony J Messina, Rachel Byrd, Keri McDonough, Darcy R Flora, Sam Schneider, Sara D Towne, Julie Prock, Lynn Donald, Dan Platt, Jane K Bentley
Publikováno v:
Blood. 140:5246-5247
Publikováno v:
Blood. 138:4982-4982
Background Valuing patients as the experts in their experience, how they live with myelodysplastic disease, and how to reframe assessments of efficacy, patient-reported outcomes (PROs) can complement traditional measurements of response. Therefore, w
Autor:
Vasily Andrianov, Keren Rachel Moss, Laura Vidal, Anthony J Messina, Liat Vidal, Kelly K. Curtis
Publikováno v:
Blood. 136:10-11
Introduction: Patient-reported outcomes (PRO) provide meaningful insight into patient perspectives on treatment effect. Clinically relevant outcomes such as improvements in overall survival (OS) and quality of life (QOL) should guide clinical decisio
Publikováno v:
Journal of Clinical Oncology. 38:e19142-e19142
e19142 Background: Patient-reported outcomes (PROs) are an important tool to assess the impact of new therapies on health-related quality of life (HRQoL). This study aimed to describe if and what PRO instruments are currently being utilized in CAR-T
Autor:
Keren Rachel Moss, Laura Vidal, Quentin E O'Brien, Anthony J Messina, Vasily Andrianov, Liat Vidal-Fisher
Publikováno v:
Blood. 134:4754-4754
Introduction Improvements in overall survival (OS) and quality of life (QoL) are clinically relevant outcomes that should guide clinical decision-making. Patients with MPNs can live with their disease for a long period of time, which increases the im
Autor:
Richard D. Hammer, Wendy Ward, Anthony J. Messina, Zheng Cui, Pedro G. Vianna, Jacqueline Gouvea, Trevor Rayborn, Dipnarine Maharaj
Publikováno v:
Heliyon, 3(10):e00438
Heliyon, Vol 3, Iss 10, Pp e00438-(2017)
Heliyon
Heliyon, Vol 3, Iss 10, Pp e00438-(2017)
Heliyon
Background In the past decade, a variety of immunotherapy approaches focused predominantly on the adaptive immune system have shown unprecedented responses in patients with advanced-stage malignancies. However, studies in spontaneous regression/compl
Publikováno v:
American String Teacher. 46:7-7
Autor:
Anthony J. Messina
Publikováno v:
American String Teacher. 17:21-22
Autor:
Anthony J. Messina
Publikováno v:
American String Teacher. 19:27-27